is the tirzepatide shortage over FDA Says of GLP-1 FDA Announced Removal of Tirzepatide

While not a replacement for medical advice, these real-life reflections shed light on a frustrating, often-overlooked part of the Mounjaro journey - and let you know youre not imagining it

"Public Health"

Individuals with a history of thyroid cancer, pancreatitis, or severe psychiatric conditions should avoid GLP-1 therapies

PMC+2PMC+2 Additive therapies help combining with Vitamin C, topical agents, sunscreen, good diet, and antioxidants can speed and strengthen visible changes

Oral supplements can be convenient, but their effectiveness varies depending on factors like formulation and an individuals body chemistry

This month, the Food and Drug Administration expanded the approval of Eli Lillys obesity drug Zepbound to explicitly cover sleep apnea as well